Devikala Gurusamy
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Response and Inflammation
Papers in
- Immunology 13
- T-cell and B-cell Immunology 6
- Immunotherapy and Immune Responses 6
- Immune cells in cancer 2
- Immune Response and Inflammation 2
- Oncology 11
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 5
- Co-authors
- Nicholas P. Restifo (5 shared papers)Robert L Eil (4 shared papers)Susan E. Waltz (7 shared papers)Suman Kumar Vodnala (4 shared papers)Tori N. Yamamoto (4 shared papers)David C. Clever (2 shared papers)Peterson Pathrose (3 shared papers)Madhusudhanan Sukumar (3 shared papers)
- Journals
- Oncogene (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Cell Reports (2 papers)JCI Insight (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesThailandHungary
In The Last Decade
Devikala Gurusamy
26 papers receiving 1.6k citations
Devikala Gurusamy's Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 947
- Immunology 580
- Cancer Research 84
- Molecular Biology 261
- Hepatology 34
Countries citing papers authored by Devikala Gurusamy
This map shows the geographic impact of Devikala Gurusamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devikala Gurusamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devikala Gurusamy more than expected).
Fields of papers citing papers by Devikala Gurusamy
This network shows the impact of papers produced by Devikala Gurusamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devikala Gurusamy. The network helps show where Devikala Gurusamy may publish in the future.
Co-authors
The 25 scholars most cited alongside Devikala Gurusamy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer Hit paper breakdown → | 2020 | 407 |
| 2 | 2017 | 184 | |
| 3 | 2019 | 150 | |
| 4 | 2020 | 133 | |
| 5 | 2019 | 128 | |
| 6 | 2019 | 68 | |
| 7 | 2017 | 57 | |
| 8 | 2022 | 57 | |
| 9 | 2009 | 54 | |
| 10 | 2013 | 46 | |
| 11 | 2021 | 44 | |
| 12 | 2018 | 42 | |
| 13 | 2010 | 38 | |
| 14 | 2019 | 38 | |
| 15 | 2015 | 34 | |
| 16 | 2019 | 25 | |
| 17 | 2011 | 22 | |
| 18 | 2021 | 19 | |
| 19 | 2014 | 14 | |
| 20 | 2014 | 14 |
About Devikala Gurusamy
Devikala Gurusamy is a scholar working on Immunology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 26 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), T-cell and B-cell Immunology (6 papers), Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers), Prostate Cancer Treatment and Research (3 papers), Immune cells in cancer (2 papers), Immune Response and Inflammation (2 papers) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Oncology (947 citations), Immunology (580 citations), Cancer Research (84 citations), Molecular Biology (261 citations) and Hepatology (34 citations). Devikala Gurusamy has collaborated with scholars based in United States, Thailand and Hungary. Frequent co-authors include Nicholas P. Restifo, Robert L Eil, Susan E. Waltz, Suman Kumar Vodnala, Tori N. Yamamoto, David C. Clever, Peterson Pathrose, Madhusudhanan Sukumar, Zhiya Yu and Rigel J. Kishton. Their work appears in journals such as Oncogene, Journal for ImmunoTherapy of Cancer, Cell Reports, JCI Insight and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.